Memorial Sloan Kettering expands Abridge rollout

New York City-based Memorial Sloan Kettering Cancer Center plans to implement Abridge’s AI platform across its system in 2025 and 2026.

Advertisement

The platform transcribes medical conversations into real-time, billable notes, allowing clinicians to spend less time on documentation and more time with patients, according to a March 5 news release.

The expansion follows a pilot program in which clinicians across cancer specialties found the platform accurately captured complex medical terms, including disease names and treatments. It also demonstrated strong performance in Spanish, Chinese, and Russian, according to the release.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Artificial Intelligence

Advertisement

Comments are closed.